Trial Profile
Cost Utility Analyses of Adalimumab Treatment in Patients With Rheumatoid Arthritis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Aug 2011
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms HEOR
- Sponsors Abbott Laboratories
- 20 Oct 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Oct 2010 Actual end date (June 2010) added as reported by ClinicalTrials.gov.
- 12 Jul 2010 Planned end date changed from 1 Jun 2010 to 1 Nov 2010 as reported by ClinicalTrials.gov.